Orally Administrable Aggregation‐Induced Emission‐Based Bionic Probe for Imaging and Ameliorating Dextran Sulfate Sodium‐Induced Inflammatory Bowel Diseases
Authors:
- 15 January 2023
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (9) , e2202420
Abstract
As macrophage infiltration is significantly related to the progression of inflammatory bowel disease (IBD), monitoring the macrophages is a valuable strategy for IBD diagnosis. However, owing to the harsh physiological environment of the gastrointestinal tract and enzymatic degradation, the development of orally administrable imaging probes for tracking macrophages remains a considerable challenge. Accordingly, herein, an orally administrable aggregation‐induced emission biomimetic probe (HBTTPIP/β‐glucan particles [GPs]) is developed for tracing macrophages; HBTTPIP/GPs can diagnose and alleviate dextran sulfate sodium (DSS)‐induced colonic inflammation and self‐report the treatment efficiency. The fluorophore HBTTPIP can effectively aggregate in GPs, restricting intramolecular rotation and activating the fluorescence of HBTTPIP. After being orally administrated, HBTTPIP/GPs are phagocytosed by intestinal macrophages, which then migrate to colonic lesions, enabling non‐invasive monitoring of the severity of IBD via in vivo fluorescence imaging. Notably, oral HBTTPIP/GPs ameliorate DSS‐induced IBD by inhibiting the expressions of pro‐inflammatory factors and improving colonic mucosal barrier function. Furthermore, these HBTTPIP/GPs realize self‐feedback of the therapeutic effects of GPs on DSS‐induced colitis. The oral biomimetic probe HBTTPIP/GPs reported herein provide a novel theranostic platform for IBD, integrating non‐invasive diagnosis of IBD in situ and the corresponding treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81727805, 82151316, 82171964, 81922033, 82001852, 82230066, 82202234)
This publication has 64 references indexed in Scilit:
- Ly6Chi Monocytes in the Inflamed Colon Give Rise to Proinflammatory Effector Cells and Migratory Antigen-Presenting CellsImmunity, 2012
- Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRILaboratory Investigation, 2012
- Guidelines for the management of inflammatory bowel disease in adultsGut, 2011
- Expression of Toll-like Receptor 2 (TLR2), TLR4, and CD14 in Biopsy Samples of Patients With Inflammatory Bowel Diseases: Upregulated Expression of TLR2 in Terminal Ileum of Patients With Ulcerative ColitisJournal of Histochemistry & Cytochemistry, 2007
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Dectin-1 is required for β-glucan recognition and control of fungal infectionNature Immunology, 2006
- Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitisCell Biochemistry and Function, 2005
- Dectin-1 Is A Major β-Glucan Receptor On MacrophagesJournal of Experimental Medicine, 2002
- Aggregation-induced emission of 1-methyl-1,2,3,4,5-pentaphenylsiloleChemical Communications, 2001
- Medical Treatment of Inflammatory Bowel DiseaseAnnual Review of Medicine, 1992